Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service
Buyer: NHS England
- Published
- 22 September 2026
- Estimated value
- £26,143,000
- Place of performance
- UK
- Procedure
- Open procedure
- Notice number
- 089823-2026
- Reference
- ocds-h6vhtk-06ae08
- Official source
- Official source
CPV codes
- 85100000Health services
Description
Intention to award the Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service. This is a a one-time, in vivo gene replacement therapy, for use in babies aged 12 months and under, that utilises an adeno-associated virus serotype 9 (AAV9) vector, modified to contain a functional copy of the human SMN1 gene. It is administered intravenously, allowing the vector to deliver the gene into motor neurones and peripheral tissues, enabling the sustained expression of survival motor neuron (SMN) protein, which is deficient or mutated in individuals with SMA. Onasemnogene abeparvovec intrathecal (OAV101 IT) is a one-time in vivo gene replacement therapy for patients with SMA, proposed to treat individuals with SMA aged 2 years and over. This intrathecal injection will be used to treat a distinct cohort of SMA patients to Zolgensma. It will be assessed via NICE’s technology appraisal programme, with an expected final guidance publication date in late 2026. Procurement was carried out in Lots for the services as detailed above. Contract values are estimated and will be dependent on number of patients actually treated at each awarde…
Lots (3)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | Lot 1 | 85100000 Health services | — |
| 2 | Lot 2 | 85100000 Health services | — |
| 3 | Lot 3 | 85100000 Health services | — |
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Northern Care Alliance NHS Foundation Trust | £1,036,000 | — |
| Sheffield Teaching Hospitals NHS Foundation Trust | £1,036,000 | — |
| Oxford University Hospitals NHS FT | £1,036,000 | — |
| University Hospitals Bristol and Weston NHS Foundation Trust | £1,036,000 | — |
| University Hospitals Southampton | £1,036,000 | — |
| University College London Hospitals NHS Foundation Trust | £1,036,000 | — |
| St George's University Hospitals NHS Foundation Trust | £1,036,000 | — |
| King's College Hospital NHS FT | £1,036,000 | — |
| The Newcastle Upon Tyne Hospitals NHS Foundation Trust | £1,036,000 | — |
| Great Ormond Street Hospital | £776,000 | — |
Official publications
- FTS · 089823-2026 · 22 September 2026
Other tenders from NHS England
- Urgent Award: Adult Male Medium Secure Deaf and Adult Male Medium Secure ABI
- Enhanced Mental Health Pathway
- Enhanced Mental Health Pathway
- NHS Vaccination and Immunisation Services
- NHS Vaccination and Immunisation Services
- Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very…
- Integrated Healthcare Services at HMP Welland Oaks
- Tier 4 Lead Provider for CAMHS
- Black Country Covid-19 Targeted Outreach Intervention: Mobile vaccination provision
- Covid Vaccinations to Nottinghamshire Housebound Patients
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £26,143,000.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.